149
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Total lesion glycolysis as an IgG4-related disease activity marker

, , , , , , , , , , , , & show all
Pages 579-584 | Received 07 Aug 2014, Accepted 19 Nov 2014, Published online: 30 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tomohiro Handa, Shoko Matsui, Hajime Yoshifuji, Yuzo Kodama, Hiroshi Yamamoto, Seijiro Minamoto, Yuko Waseda, Yasuharu Sato, Keishi Kubo, Tsuneyo Mimori, Tsutomu Chiba, Toyohiro Hirai & Michiaki Mishima. (2018) Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. Modern Rheumatology 28:5, pages 838-844.
Read now

Articles from other publishers (17)

Mei-Fang Cheng, Yue Leon Guo, Ruoh-Fang Yen, Yen-Wen Wu & Hsiu-Po Wang. (2023) Pretherapy 18 F-FDG PET/CT in Predicting Disease Relapse in Patients With Immunoglobulin G4-Related Disease: A Prospective Study . Korean Journal of Radiology 24:6, pages 590.
Crossref
Rie Oshima, Ryotaro Ikeguchi, Sho Wako, Takafumi Mizuno, Kayoko Abe, Masayuki Nitta, Yoshihiro Muragaki, Takakazu Kawamata, Kenta Masui, Tomoko Yamamoto, Noriyuki Shibata, Yuko Shimizu & Kazuo Kitagawa. (2022) IgG4 ‐related brain pseudotumor mimicking CNS lymphoma. A case report . Neuropathology 42:6, pages 526-533.
Crossref
Tomohiro Kameda, Shusaku Nakashima, Katsuya Mitamura, Yuka Yamamoto, Takashi Norikane, Hiromi Shimada, Risa Wakiya, Mikiya Kato, Taichi Miyagi, Koichi Sugihara, Rina Mino, Mao Mizusaki, Norimitsu Kadowaki & Hiroaki Dobashi. (2022) FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis. Scientific Reports 12:1.
Crossref
Zhiqian Bai, Tianshu Zhou, Zhihua Yu, Yu Chen & Lingli Dong. (2022) Clinical value of 18F-FDG PET/CT in IgG4-related disease. Annals of Nuclear Medicine 36:7, pages 651-660.
Crossref
Francesco Dondi, Domenico Albano, Pietro Bellini, Giulia Volpi, Raffaele Giubbini & Francesco Bertagna. (2022) 18F-fluorodeoxyglucose PET and PET/computed tomography for the evaluation of immunoglobulin G4-related disease: a systematic review. Nuclear Medicine Communications 43:6, pages 638-645.
Crossref
Ken Nagahata, Masatoshi Kanda, Ryuta Kamekura, Masanari Sugawara, Naoya Yama, Chisako Suzuki, Kenichi Takano, Masamitsu Hatakenaka & Hiroki Takahashi. (2021) Abnormal [18F]fluorodeoxyglucose accumulation to tori tubarius in IgG4-related disease. Annals of Nuclear Medicine 36:2, pages 200-207.
Crossref
Olimpia Orozco-Gálvez, Andreu Fernández-Codina, Marc Simó-Perdigo, Iago Pinal-Fernández & Fernando Martínez-Valle. (2021) Response to Treatment in IgG4-Related Disease Assessed by Quantitative PET/CT Scan. Clinical Nuclear Medicine 46:6, pages e307-e311.
Crossref
Katsuya Mitamura, Hanae Arai-Okuda, Yuka Yamamoto, Takashi Norikane, Yasukage Takami, Kengo Fujimoto, Risa Wakiya, Hiroki Ozaki, Hiroaki Dobashi & Yoshihiro Nishiyama. (2020) Disease activity and response to therapy monitored by [18F]FDG PET/CT using volume-based indices in IgG4-related disease. EJNMMI Research 10:1.
Crossref
Marco Lanzillotta, Gaia Mancuso & Emanuel Della-Torre. (2020) Advances in the diagnosis and management of IgG4 related disease. BMJ, pages m1067.
Crossref
Alfred O. Ankrah, Lambert F. R. Span, Hans C. Klein, Pim A. de Jong, Rudi A. J. O. Dierckx, Thomas C. Kwee, Mike M. Sathekge & Andor W. J. M. Glaudemans. (2018) Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections. European Journal of Nuclear Medicine and Molecular Imaging 46:1, pages 174-183.
Crossref
Mitsuhiro Akiyama & Tsutomu Takeuchi. (2018) IgG4-Related Disease: Beyond Glucocorticoids. Drugs & Aging 35:4, pages 275-287.
Crossref
A. F. Karim, L. E. M. Eurelings, R. D. Bansie, P. M. van Hagen, J. A. M. van Laar & W. A. Dik. (2018) Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease. Mediators of Inflammation 2018, pages 1-6.
Crossref
Alvise Berti, Emanuel Della-Torre, Francesca Gallivanone, Carla Canevari, Raffaella Milani, Marco Lanzillotta, Corrado Campochiaro, Giuseppe Alvise Ramirez, Emanuele Bozzalla Cassione, Enrica Bozzolo, Federica Pedica, Isabella Castiglioni, Paolo Giorgio Arcidiacono, Gianpaolo Balzano, Massimo Falconi, Luigi Gianolli & Lorenzo Dagna. (2017) Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. Rheumatology 56:12, pages 2084-2092.
Crossref
Tomomi Nobashi, Takeshi Kubo, Yuji Nakamoto, Tomohiro Handa, Sho Koyasu, Takayoshi Ishimori, Michiaki Mishima & Kaori Togashi. (2016) 18 F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease . Journal of Nuclear Medicine 57:12, pages 1899-1904.
Crossref
Mitsuhiro Akiyama, Hidekata Yasuoka, Kunihiro Yamaoka, Katsuya Suzuki, Yuko Kaneko, Harumi Kondo, Yoshiaki Kassai, Keiko Koga, Takahiro Miyazaki, Rimpei Morita, Akihiko Yoshimura & Tsutomu Takeuchi. (2016) Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. Arthritis Research & Therapy 18:1.
Crossref
Tomomi Nobashi, Yuji Nakamoto, Takeshi Kubo, Takayoshi Ishimori, Tomohiro Handa, Kiminobu Tanizawa, Kohei Sano, Michiaki Mishima & Kaori Togashi. (2016) The utility of PET/CT with 68Ga-DOTATOC in sarcoidosis: comparison with 67Ga-scintigraphy. Annals of Nuclear Medicine 30:8, pages 544-552.
Crossref
Tomohiro Handa & Sonoko Nagai. (2016) Clinical Utility and Problems of Blood Biomarkers in Patientswith Sarcoidosis. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders 36:1_2, pages 53-58.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.